Seven patients with vascular dementia completed an 8month randomized double-blind crossover trial of bromocriptine i n a dosage of u p to 30 mg per day. Patients were assessed using a modified UCLA Parkinson Rating Scale of symptoms and signs, and neuropsychological testing including the Wechsler Ad
Temporal Changes in Brain Volume and Cognition in a Randomized Treatment Trial of Vascular Dementia
β Scribed by Joseph P. Broderick; Mary Gaskill; Atam Dhawan; Jane C. Khoury
- Book ID
- 109266714
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 104 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1051-2284
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Objectives: The efficacy and tolerability of sodium valproate 2 x 240 mg compared to placebo were investigated in aggressive behavior in dementia. ## Design: A randomized, placebo controlled, double-blind cross-over design. the trial included a baseline period (one week); a placebo period (thr
Several studies have demonstrated that ambroxol stimulates surfactant synthesis and has antioxidative and antiinflammatory effects. We investigated the effect of ambroxol on lung function in newborns with respiratory distress syndrome (RDS) weighing <1,500g. In all, 102 newborns were enrolled (52 re